Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Keyomarsi

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 1, 1996
Expression of cytochromes P450 in human breast tissue and tumorsZ Huang, M J Fasco, H L Figge, et al.
Cell|November 19, 1993
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinasesJ W Harper, G R Adami, N Wei, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 1999
Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductaseS Rao, D C Porter, X Chen, et al.
Cancer Research|January 15, 1994
Cyclin E, a potential prognostic marker for breast cancerK Keyomarsi, N O'Leary, G Molnar, et al.
The Journal of Biological Chemistry|January 17, 1997
Molecular cloning, characterization, and regulation of the human mitochondrial serine hydroxymethyltransferase geneP J Stover, L H Chen, J R Suh, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 24, 1996
Cyclin E, a redundant cyclin in breast cancerJ Gray-Bablin, J Zalvide, M P Fox, et al.
Journal of the National Cancer Institute|December 21, 2000
Protection of normal proliferating cells against chemotherapy by staurosporine-mediated, selective, and reversible G(1) arrestX Chen, M Lowe, T Herliczek, et al.
Cancer Gene Therapy|May 7, 2011
MDA-7 results in downregulation of AKT concomitant with apoptosis and cell cycle arrest in breast cancer cellsV Valero, H Wingate, S Chada, et al.
Molecular and Cellular Biology|August 18, 2001
Tumor-specific proteolytic processing of cyclin E generates hyperactive lower-molecular-weight formsD C Porter, N Zhang, C Danes, et al.
Science (New York, N.Y.)|September 5, 2001
Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligaseD M Koepp, L K Schaefer, X Ye, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 1, 1996
Expression of cytochromes P450 in human breast tissue and tumorsZ Huang, M J Fasco, H L Figge, et al.
Cell|November 19, 1993
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinasesJ W Harper, G R Adami, N Wei, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 1999
Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductaseS Rao, D C Porter, X Chen, et al.
Cancer Research|January 15, 1994
Cyclin E, a potential prognostic marker for breast cancerK Keyomarsi, N O'Leary, G Molnar, et al.
The Journal of Biological Chemistry|January 17, 1997
Molecular cloning, characterization, and regulation of the human mitochondrial serine hydroxymethyltransferase geneP J Stover, L H Chen, J R Suh, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 24, 1996
Cyclin E, a redundant cyclin in breast cancerJ Gray-Bablin, J Zalvide, M P Fox, et al.
Journal of the National Cancer Institute|December 21, 2000
Protection of normal proliferating cells against chemotherapy by staurosporine-mediated, selective, and reversible G(1) arrestX Chen, M Lowe, T Herliczek, et al.
Cancer Gene Therapy|May 7, 2011
MDA-7 results in downregulation of AKT concomitant with apoptosis and cell cycle arrest in breast cancer cellsV Valero, H Wingate, S Chada, et al.
Molecular and Cellular Biology|August 18, 2001
Tumor-specific proteolytic processing of cyclin E generates hyperactive lower-molecular-weight formsD C Porter, N Zhang, C Danes, et al.
Science (New York, N.Y.)|September 5, 2001
Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligaseD M Koepp, L K Schaefer, X Ye, et al.
Pageof 5